Nohla Therapeutics Email Format

Biotechnology ResearchWashington, United States0-1 Employees

Nohla Therapeutics is a Seattle-based biotechnology company focused on developing universal, off-the-shelf cellular therapies for patients with critical diseases. Its leading program targets hematopoietic recovery and chemotherapy-induced neutropenia, with plans to extend the approach to additional indications. The company builds on a cord blood expansion platform developed at Fred Hutchinson Cancer Research Center. This work places Nohla in the field of cellular therapies for hematologic conditions and other life-threatening illnesses.

Its target market includes patients with hematologic malignancies and other critical diseases, as well as the clinicians and medical centers that administer cellular therapies. In 2018, Nohla appointed Sarah Noonberg as Chief Medical Officer, reflecting ongoing leadership development as it advances its program.

Sign up for free to view info

Company overview Employee directory